Diabetes
The question
To ask the Secretary of State for Health and Social Care, when NICE plans to review (a) guideline NG17 for Type 1 diabetes in adults and (b) guideline NG18 for Diabetes (type 1 and type 2) in children and young people; and what the timelines are for the next updates.
Answered by Dr Zubir Ahmed
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for translating evidence into authoritative evidence-based guidance for the health and care system on best practice, in order to drive improved outcomes for patients.
NICE currently has no plans to update guidelines NG17 and NG18. NICE takes a proactive approach to surveillance, monitoring for changes in the evidence base that may impact on its recommendations. Topics for new or updated guidance are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by an integrated, cross-organisational prioritisation board, chaired by NICE’s Chief Medical Officer.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →